Natural killer cell-based immunotherapy for acute myeloid leukemia

Jing Xu1, Ting Niu2

  • 1Department of Hematology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Summary

Natural killer (NK) cell immunotherapy offers a promising approach to combat acute myeloid leukemia (AML) relapse. This review explores various NK cell-based strategies to improve treatment outcomes and prolong patient survival.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K